“ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer” (2017) Biomedical Research and Therapy, 4(S), p. S33. doi:10.15419/bmrat.v4iS.243.